Venus Concept Inc. (VERO)
NASDAQ: VERO · Real-Time Price · USD
0.303
-0.009 (-2.88%)
At close: Nov 20, 2024, 4:00 PM
0.296
-0.007 (-2.31%)
Pre-market: Nov 21, 2024, 7:15 AM EST

Company Description

Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally.

Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin.

The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system.

In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing.

The company is headquartered in Toronto, Canada.

Venus Concept Inc.
Venus Concept logo
Country Canada
Industry Medical Devices
Sector Healthcare
Employees 304
CEO Rajiv Kanishka De Silva

Contact Details

Address:
235 Yorkland Boulevard, Suite 900
Toronto, ON M2J 4Y8
Canada
Phone 877 848 8430
Website venus.ai

Stock Details

Ticker Symbol VERO
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001409269
CUSIP Number 92332W105
ISIN Number US92332W2044
Employer ID 06-1681204
SIC Code 3841

Key Executives

Name Position
Rajiv Kanishka Liyanaarchchie De Silva Chief Executive Officer and Director
Dr. Hemanth Jacob Varghese CFA, Ph.D. President and Chief Operating Officer
Ross J. Portaro Executive Vice President and GM of Global Sales and Marketing
Michael Mandarello General Counsel and Corporate Secretary
William H. McGrail Executive Vice President of Technical Operations and Compliance
Anat Kotler Head of Marketing and Product Management
Anna Georgiadis Chief Human Resources Officer
Dr. Yoni Iger Head of Scientific and Clinical Affairs
Joyce Morris Head of Sales - Canada
Ognjen Petrovic Head of Research & Development, Robotics, Software

Latest SEC Filings

Date Type Title
Nov 13, 2024 10-Q Quarterly Report
Nov 13, 2024 8-K Current Report
Nov 4, 2024 8-K Current Report
Nov 1, 2024 EFFECT Notice of Effectiveness
Oct 24, 2024 S-3 Registration statement under Securities Act of 1933
Oct 8, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Oct 3, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Sep 30, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Sep 30, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Sep 30, 2024 8-K Current Report